Merlin Neutralizes the Inhibitory Effect of Mdm2 on p53

Hongtae Kim, Noh‐Jin Kwak, Joo‐Yong Lee, Byung Hyune Choi, Young‐Min Lim, Young Jin Ko, Young-Hoon Kim, Pil‐Woo Huh, Kweon-Haeng Lee, Hyoung Kyun Rha,

Journal of Biological Chemistry · 2004 · 69 citations · 32 references

DOIFull text

Open access

Concepts

Abstract

The stability of p53 tumor suppressor is regulated by Mdm2 via the ubiquitination and proteasome-mediated proteolysis pathway. The c-Abl and PTEN tumor suppressors are known to stabilize p53 by blocking the Mdm2-mediated p53 degradation. This study investigated the correlation between p53 and merlin, a neurofibromatosis 2 (NF2)-related tumor suppressor, in association with the Mdm2 function. The results showed that merlin increased the p53 stability by inhibiting the Mdm2-mediated degradation of p53, which accompanied the increase in the p53-dependent transcriptional activity. The stabilization of p53 by merlin appeared to be accomplished through Mdm2 degradation, and the N-terminal region of merlin was responsible for this novel activity. This study also showed that overexpression of merlin-induced apoptosis of cells depending preferentially on p53 in response to the serum starvation or a chemotherapeutic agent. These results suggest that merlin could be a positive regulator of p53 in terms of tumor suppressor activity, and provide the promising therapeutic means for treating tumors with non-functional merlin or Mdm2 overexpression. The stability of p53 tumor suppressor is regulated by Mdm2 via the ubiquitination and proteasome-mediated proteolysis pathway. The c-Abl and PTEN tumor suppressors are known to stabilize p53 by blocking the Mdm2-mediated p53 degradation. This study investigated the correlation between p53 and merlin, a neurofibromatosis 2 (NF2)-related tumor suppressor, in association with the Mdm2 function. The results showed that merlin increased the p53 stability by inhibiting the Mdm2-mediated degradation of p53, which accompanied the increase in the p53-dependent transcriptional activity. The stabilization of p53 by merlin appeared to be accomplished through Mdm2 degradation, and the N-terminal region of merlin was responsible for this novel activity. This study also showed that overexpression of merlin-induced apoptosis of cells depending preferentially on p53 in response to the serum starvation or a chemotherapeutic agent. These results suggest that merlin could be a positive regulator of p53 in terms of tumor suppressor activity, and provide the promising therapeutic means for treating tumors with non-functional merlin or Mdm2 overexpression. Neurofibromatosis type 2 (NF2) 1The abbreviations used are: NF2, neurofibromatosis type 2; CNS, central nervous system; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; moi, multiplicity of infection; GFP, green fluorescent protein; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; HEK, human embryonic kidney. is an autosomal dominant disorder that occurs in ∼1 of 40,000 of births. NF2 is characterized by the formation of a bilateral vestibular schwannoma, which results in a high predisposition to central nervous system (CNS) tumors, cafe-au-lait spots or other skin lesions, and lens opacities (4Short M.P. Martuza R.L. Huson S.M. Huson S.M. Hughes R.A.C. The Neurofibromatoses: A Practical and Clinical Overview. Chapman and Hall Medical Press, London1994: 414-444Google Scholar). It is caused by the disruption of an NF2 tumor suppressor gene located on chromosome 22q12 (1Evans D.G. Huson S.M. Donnai D. Neary W. Blair V. Newton V. Strachan T. Harris R. J. Med. Genet. 1992; 29: 841-846Crossref PubMed Scopus (425) Google Scholar, 2Rouleau G.A. Merel P. Lutchman M. Sanson M. Zucman J. Marineau C. Hoang-Xuan K. Demczuk S. Desmaze C. Plougastel B. Nature. 1993; 363: 515-521Crossref PubMed Scopus (1233) Google Scholar, 3Trofatter J.A. MacCollin M.M. Rutter J.L. Murrell J.R. Duyao M.P. Parry D.M. Eldridge R. Kley N. Menon A.G. Pulaski K. Cell. 1993; 72: 791-800Abstract Full Text PDF PubMed Scopus (1134) Google Scholar). The NF2 gene encodes merlin (also known as schwannomin) with 595 amino acids. Many studies have suggested that merlin is involved in regulating cell growth and proliferation (5Ikeda K. Saeki Y. Gonzalez-Agosti C. Ramesh V. Chiocca E.A. J. Neurosurg. 1999; 91: 85-92Crossref PubMed Scopus (67) Google Scholar, 6Morrison H. Sherman L.S. Legg J. Banine F. Isacke C. Haipek C.A. Gutmann D.H. Ponta H. Herrlich P. Genes Dev. 2001; 15: 968-980Crossref PubMed Scopus (455) Google Scholar, 7Sherman L. Xu H.M. Geist R.T. Saporito-Irwin S. Howells N. Ponta H. Herrlich P. Gutmann D.H. Oncogene. 1997; 15: 2505-2509Crossref PubMed Scopus (205) Google Scholar). Mice with conditional homozygous NF2 mutations targeted to the neural crest and Schwann cells can develop schwannomas, Schwann-cell hyperplasia, cataracts, and osseous metastases (8Giovannini M. Robanus-Maandag E. van der Valk M. Niwa-Kawakita M. Abramowski V. Goutebroze L. Woodruff J.M. Berns A. Thomas G. Genes Dev. 2000; 14: 1617-1630PubMed Google Scholar). However, germ line heterozygous NF2 mutant mice develop a variety of aggressive malignancies with metastatic properties, which are not typically observed in NF2 patients (9McClatchey A.I. Saotome I. Mercer K. Crowley D. Gusella J.F. Bronson R.T. Jacks T. Genes Dev. 1998; 12: 1121-1133Crossref PubMed Scopus (324) Google Scholar). Overall, these reports suggest that merlin is both a tumor and metastasis suppressor. In addition, overexpression of wild-type merlin can reverse the Ha-Ras-induced malignant phenotypes such as anchorage- and contact-independent cell growth in NIH3T3 cells (10Tikoo A. Varga M. Ramesh V. Gusella J. Maruta H. J. Biol. Chem. 1994; 269: 23387-23390Abstract Full Text PDF PubMed Google Scholar). The p53 tumor suppressor is short-lived and is present at low levels in normal cells (11Levine A.J. Cell. 1997; 88: 323-331Abstract Full Text Full Text PDF PubMed Scopus (6805) Google Scholar, 12Bates S. Vousden K.H. Cell. Mol. Life. Sci. 1999; 55: 28-37Crossref PubMed Scopus (271) Google Scholar). It plays a key role in the cellular responses to a variety of stresses via post-translational modifications and accumulation in nucleus (11Levine A.J. Cell. 1997; 88: 323-331Abstract Full Text Full Text PDF PubMed Scopus (6805) Google Scholar, 13Gottlieb T.M. Oren M. Biochim. Biophys. Acta. 1996; 1287: 77-102Crossref PubMed Scopus (511) Google Scholar). Activated p53 induces growth arrest and apoptosis by transactivating p21waf/cip1 and Bax genes, respectively (11Levine A.J. Cell. 1997; 88: 323-331Abstract Full Text Full Text PDF PubMed Scopus (6805) Google Scholar, 13Gottlieb T.M. Oren M. Biochim. Biophys. Acta. 1996; 1287: 77-102Crossref PubMed Scopus (511) Google Scholar). The transcriptional activity and stability of p53 are tightly regulated by the mdm2 proto-oncogene (14Freedman D.A. Wu L. Levine A.J. Cell. Mol. Life. Sci. 1999; 55: 96-107Crossref PubMed Scopus (498) Google Scholar). Mdm2 binds to the transcriptional activation domain of p53 in the nucleus and translocates it to the cytoplasm where p53 is rapidly degraded via an ubiquitin-proteasome system (15Momand J. Zambetti G.P. Olson D.C. George D. Levine A.J. Cell. 1992; 69: 1237-1245Abstract Full Text PDF PubMed Scopus (2850) Google Scholar, 16Oliner J.D. Pietenpol J.A. Thiagalingam S. Gyuris J. Kinzler K.W. Vogelstein B. Nature. 1993; 362: 857-860Crossref PubMed Scopus (1329) Google Scholar, 17Chen J. Marechal V. Levine A.J. Mol. Cell. Biol. 1993; 13: 4107-4114Crossref PubMed Scopus (634) Google Scholar). The p53 degradation by Mdm2 inhibits p53-dependent gene expression and apoptosis (18Honda R. Tanaka H. Yasuda H. FEBS Lett. 1997; 420: 25-27Crossref PubMed Scopus (1627) Google Scholar, 19Haupt Y. Maya R. Kazaz A. Oren M. Nature. 1997; 387: 296-299Crossref PubMed Scopus (3790) Google Scholar, 20Kubbutat M.H. Jones S.N. Vousden K.H. Nature. 1997; 387: 299-303Crossref PubMed Scopus (2880) Google Scholar). Since mdm2 is a transcriptional target gene of p53, they create a negative auto-regulatory feedback loop (21Wu X. Bayle J.H. Olson D. Levine A.J. Genes Dev. 1993; 7: 1126-1132Crossref PubMed Scopus (1665) Google Scholar). Neutralizing the inhibitory effect of Mdm2 may be an efficient and common mechanism by which p53 is regulated. Indeed, recent studies have shown that two tumor suppressor proteins, c-Abl and PTEN, enhanced p53 activity by inhibiting the Mdm2-mediated degradation of p53 (22Sionov R.V. Moallem E. Berger M. Kazaz A. Gerlitz O. Ben-Neriah Y. Oren M. Haupt Y. J. Biol. Chem. 1999; 274: 8371-8374Abstract Full Text Full Text PDF PubMed Scopus (101) Google Scholar, 23Mayo L.D. Dixon J.E. Durden D.L. Tonks N.K. Donner D.B. J. Biol. Chem. 2002; 277: 5484-5489Abstract Full Text Full Text PDF PubMed Scopus (298) Google Scholar). Subsequently, C-Abl was known to prevent the ubiquitination and nuclear export of p53 by Mdm2 via phosphorylation of Mdm2 at the Tyr394 residue both in vivo and in vitro (24Sionov R.V. Coen S. Goldberg Z. Berger M. Bercovich B. Ben-Neriah Y. Ciechanover A. Haupt Y. Mol. Cell. Biol. 2001; 21: 5869-5878Crossref PubMed Scopus (87) Google Scholar, 25Goldberg Z. Sionov R.V. Berger M. Zwang Y. Perets R. Van Etten R.A. Oren M. Taya Y. Haupt Y. EMBO J. 2002; 21: 3715-3727Crossref PubMed Scopus (163) Google Scholar). PTEN was reported to restrict Mdm2 in the cytoplasm for degradation, possibly by inhibiting the phosphorylation by Akt at the Ser166 and Ser186 residues as well as the nuclear import of Mdm2 (23Mayo L.D. Dixon J.E. Durden D.L. Tonks N.K. Donner D.B. J. Biol. Chem. 2002; 277: 5484-5489Abstract Full Text Full Text PDF PubMed Scopus (298) Google Scholar, 38Mayo L.D. Donner D.B. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 11598-11603Crossref PubMed Scopus (971) Google Scholar). Previously, the functional cooperation between merlin and p53 tumor suppressors has been implicated in a mutation study (9McClatchey A.I. Saotome I. Mercer K. Crowley D. Gusella J.F. Bronson R.T. Jacks T. Genes Dev. 1998; 12: 1121-1133Crossref PubMed Scopus (324) Google Scholar). Therefore, this study investigated if merlin also increases the p53 activity as PTEN or c-Abl does. We found that merlin enhanced the stability and activity of p53 by inducing Mdm2 degradation. Plasmids—The expression plasmids for the NF-κB p65 subunit (pcDNA-p65), merlin (pcDNA-NF2), (26Kim J. Kim H. Jeun S. Rha S. Kim Y. Ko Y. Won J. Lee K. Rha H. Wang Y. Biochem. Biophys. Res. Commun. 2002; 296: 1295-1302Crossref PubMed Scopus (29) Google Scholar) GAL4 DBD-fused p53 (pSG-p53) (27Kim H. Lim J.Y. Kim Y.H. Kim H. Park S.H. Lee K.H. Han H. Jeun S.S. Lee J.H. Rha H.K. Mol. Cells. 2002; 14: 108-114PubMed Google Scholar), and intact p53 (pcDNA-p53) (29Lee H. Kim H.T. Yun Y. J. Biol. Chem. 1998; 273: 19786-19791Abstract Full Text Full Text PDF PubMed Scopus (27) Google Scholar) were described previously. The plasmids for the NF2 deletion mutants (M1, M2, M3, and M4) were also described previously (26Kim J. Kim H. Jeun S. Rha S. Kim Y. Ko Y. Won J. Lee K. Rha H. Wang Y. Biochem. Biophys. Res. Commun. 2002; 296: 1295-1302Crossref PubMed Scopus (29) Google Scholar). The p21 promoter-luciferase reporter plasmid (p21-Luc) is constructed by inserting p21 promoter region from p21-CAT (30Han J. Yoo H.Y. Choi B.H. Rho H.M. Biochem. Biophys. Res. Commun. 2000; 272: 525-530Crossref PubMed Scopus (58) Google Scholar) into the pGL3-basic plasmid (Promega). The expression plasmid for the GAL4 DBD-fused transactivating domain of Elk (pFA2-Elk1), and the luciferase reporters with the GAL4 DNA binding sites (pFR-Luc) and the NF-κB response elements (pNF-κB-Luc) were purchased from Stratagene. The human Mdm2 expression plasmid (pcDNA-Mdm2) was kindly provided from Dr. Carl Maki (Harvard University). The expression plasmid for the full-length Mdm2 in reverse orientation (pcDNA-As-Mdm2) was constructed by cloning the PCR fragment in pcDNA3.1 (Invitrogen, San Diego. CA) the and NIH3T3 cells and cell and were in serum and cell and and human cell and were in serum and The was used to the plasmids to the the reporter NIH3T3 cells were in a the cells were with of reporter plasmids and of expression of the DNA was between the pcDNA3.1 The cells were and the luciferase activity was for the could not be used merlin the expression of of the the were and the results were of NIH3T3 cells were with the cells were at a and in the of in the the were and merlin expression was by merlin was kindly provided by Dr. Jeun of The green fluorescent was purchased from The were in the human embryonic cell and the were by the in of of the were from the of at the of The were in of a 2 CHAPS, and a of and of and and The was for and at for The was at for at to the The in the was the of were used for the and for merlin, p53, and Mdm2 and p21 were from The cells were with and for on in a The was by at for at The was to the and the proteins, the were with in This was by the with the and The were of DNA cells were in the or cells were with serum in a The human and and human and cell were with or at a of for 2 which the was and with the these cells were also with serum as the cells were and with The cell were in of a and and on for at for the DNA was from the by a of and a of at the were at for The were in of a and A and for at The were on a in a cells were at cells well in a the human and and human cell and were with or at a of for 2 which the was and with the cells were with an of or In the of the and the cells were with the of at was with the at a of for The were in a of and the at were a The results were the The of cell was the from the from the The are as the the of cell is from two in of and p53 in was reported that the cooperation between the and p53 mutations are in tumor in mice (9McClatchey A.I. Saotome I. Mercer K. Crowley D. Gusella J.F. Bronson R.T. Jacks T. Genes Dev. 1998; 12: 1121-1133Crossref PubMed Scopus (324) Google Scholar). The c-Abl or PTEN tumor suppressor was known to both the and the transcriptional activity of p53 (22Sionov R.V. Moallem E. Berger M. Kazaz A. Gerlitz O. Ben-Neriah Y. Oren M. Haupt Y. J. Biol. Chem. 1999; 274: 8371-8374Abstract Full Text Full Text PDF PubMed Scopus (101) Google Scholar, 23Mayo L.D. Dixon J.E. Durden D.L. Tonks N.K. Donner D.B. J. Biol. Chem. 2002; 277: 5484-5489Abstract Full Text Full Text PDF PubMed Scopus (298) Google Scholar). Therefore, it was that the of merlin and p53 are also as in the of c-Abl and In this the levels of p53 and merlin were in cell and and the from shown in both p53 and merlin were in the cells and was in the or In the of the the expression levels of both merlin and p53 were in the shown in the that merlin also showed a high p53 expression and Overall, these results suggest that the levels of p53, and merlin be to other in cell and tumor p53 and the correlation between the p53 and merlin this study on the effect of merlin on the p53 levels as suggested from the of c-Abl and NIH3T3 cells merlin or the cell line were NIH3T3 cells were used the tumor suppressor activity of merlin is well known in this cell The levels of p53 and a transcriptional target of p53, were shown in merlin overexpression in an increase in the levels of p53 and This merlin effect on p53 and p21 levels was a expression of p53 and merlin the with the the cell overexpression of merlin in an increase in the cellular levels of p53 and p21 in a effect of merlin was shown on the promoter not These results suggest that merlin could the accumulation of The effect of merlin on the p53 activity was by the reporter in the system p21 promoter The p21 promoter activity was increased by the of p53 and merlin depending on the of merlin the activity of the NF-κB p65 subunit was by merlin as reported previously (26Kim J. Kim H. Jeun S. Rha S. Kim Y. Ko Y. Won J. Lee K. Rha H. Wang Y. Biochem. Biophys. Res. Commun. 2002; 296: 1295-1302Crossref PubMed Scopus (29) Google Scholar). the that merlin p53 by DNA binding activity for the GAL4 DNA binding domain p53 was constructed and for the merlin effect in NIH3T3 shown in merlin transcriptional activity of it the activity of on the GAL4 reporter (pFR-Luc) in a The was also increased with the increase in the of merlin these results suggest that merlin p53 via the Mdm2-mediated of The stabilization of p53 by merlin an if merlin p53 from Mdm2-mediated degradation. This was by the effect of merlin on the p53 degradation caused by the expression of Mdm2 in NIH3T3 the of was by which was by the of merlin in a The functional of this in the reporter system also showed that merlin the inhibitory effect of Mdm2 on the p53 transcriptional activity in a p53 via Mdm2 the that merlin p53 degradation, if the merlin effect on p53 stability is A plasmid an of human Mdm2 (pcDNA-As-Mdm2) was constructed to the Mdm2 expression in human cells with type The cells were with the and the expression plasmids for merlin and p53, and the levels of p53, Mdm2 and merlin were by the Mdm2 and the of the expression of merlin also in the of the Mdm2 it the p53 of merlin and showed effect on the p53 with the of This that the effect of merlin on p53 stability is The merlin effect was on the Mdm2 the to if it at the transcriptional or at the shown in of merlin the of Mdm2 in NIH3T3 This that merlin induces the of merlin not the gene expression not The N-terminal for the of an region and a domain Gutmann D.H. J. Sci. 2002; PubMed Scopus Google Scholar). The functional of merlin involved in the Mdm2 degradation were deletion mutants of merlin shown in the and deletion mutants of merlin a in the Mdm2 as as the wild-type merlin, the or deletion mutants showed effect on the Mdm2 the and mutants the N-terminal amino the domain of merlin that in the and This that the N-terminal region of merlin the domain is for and p53 on and on the it was that merlin the growth arrest apoptosis of cells preferentially in cooperation with cell merlin and or a cell line were of serum for and the of cell apoptosis was by a DNA The cell line showed of the DNA observed in apoptosis were in the two cells In to this merlin-induced apoptosis is on p53 the DNA were in and cells The human and with or were of serum for and the of cell apoptosis was by a DNA of apoptosis was observed in cells p53 with or and However, cells with showed the DNA observed in the showed a effect and results were observed in the human cells with or p53 not Overall, these results suggest that merlin could apoptosis preferentially in cells with wild-type the effect of merlin on cell growth DNA the cell merlin or the human cells were with a for and the of the cells were an shown in expression of merlin the effect of on the growth of NIH3T3 The of human cells with wild-type p53 was that of the cells p53 in response to the of of the of cells by that of We also observed results with the cell cell and cell not These results suggest that merlin induces apoptosis in response to at in through p53 Previously, and p53 mutant mice showed a of tumor of the mutant mice (9McClatchey A.I. Saotome I. Mercer K. Crowley D. Gusella J.F. Bronson R.T. Jacks T. Genes Dev. 1998; 12: 1121-1133Crossref PubMed Scopus (324) Google Scholar). In addition, two tumor c-Abl and PTEN increased the stability and activity of p53 to an increase in the apoptosis This that cooperation between p53 and other tumor suppressors PTEN, and be for the of tumor In this it was found that was a correlation between the p53 and merlin levels in tumor Therefore, this study investigated the functional cooperation between p53 and The results showed that merlin the accumulation of p53 by a key regulator of p53 degradation, which increased the p53 transcriptional activity The N-terminal region of merlin was responsible for this novel activity which also the of merlin effect on p53 and The activation of p53 by merlin to apoptosis of cells in response to stresses The p53 activation by merlin is to on the p53 stabilization at the in it may not be merlin not to the p53 promoter at the transcriptional or p53 transcriptional activity on the results the p53 the The mechanism of merlin-induced Mdm2 degradation is not However, the transcriptional of Mdm2 expression by merlin could be also in this overexpression The that merlin p53, a key of Mdm2 also this Therefore, merlin may the stability of Mdm2 or restrict it in the cytoplasm for degradation as the of PTEN (23Mayo L.D. Dixon J.E. Durden D.L. Tonks N.K. Donner D.B. J. Biol. Chem. 2002; 277: 5484-5489Abstract Full Text Full Text PDF PubMed Scopus (298) Google Scholar). In the of it is known to stabilize and p53 Mdm2 degradation (22Sionov R.V. Moallem E. Berger M. Kazaz A. Gerlitz O. Ben-Neriah Y. Oren M. Haupt Y. J. Biol. Chem. 1999; 274: 8371-8374Abstract Full Text Full Text PDF PubMed Scopus (101) Google Scholar). The phosphorylation of Mdm2 by c-Abl at Tyr394 was reported to the ubiquitination and nuclear export of p53 by Mdm2 (24Sionov R.V. Coen S. Goldberg Z. Berger M. Bercovich B. Ben-Neriah Y. Ciechanover A. Haupt Y. Mol. Cell. Biol. 2001; 21: 5869-5878Crossref PubMed Scopus (87) Google Scholar, 25Goldberg Z. Sionov R.V. Berger M. Zwang Y. Perets R. Van Etten R.A. Oren M. Taya Y. Haupt Y. EMBO J. 2002; 21: 3715-3727Crossref PubMed Scopus (163) Google Scholar). Mdm2 overexpression has been observed in of human tumors by gene increased or enhanced Mdm2 was reported to and both and cells S.S. George D.L. EMBO J. PubMed Scopus (634) Google Scholar, C.A. Mol. Cell. Biol. 1993; 13: PubMed Scopus Google Scholar), and tumor in mice (14Freedman D.A. Wu L. Levine A.J. Cell. Mol. Life. Sci. 1999; 55: 96-107Crossref PubMed Scopus (498) Google Scholar). Therefore, the inhibitory effect of Mdm2 be an efficient and common mechanism of cells the of In to the of merlin, c-Abl and PTEN shown the tumor suppressor and were also reported to stabilize and p53 by inhibiting Mdm2 activity Genes Dev. 1998; 12: PubMed Scopus Google Scholar, A. E. Genes Dev. 1998; 12: PubMed Scopus Google Scholar, M. M. C. S. D.M. Mol. Cell. 1998; Full Text Full Text PDF PubMed Scopus Google Scholar). The binds and Mdm2 in the J.D. D. Biol. 1999; PubMed Scopus Google Scholar). binds inhibiting both Mdm2 expression A. E. Genes Dev. 1998; 12: PubMed Scopus Google Scholar) and the between Mdm2 and which is for p53 degradation M. M. C. S. D.M. Mol. Cell. 1998; Full Text Full Text PDF PubMed Scopus Google Scholar). It is to be if merlin or other means to the Mdm2 activity. However, is to be the for merlin, is in the NIH3T3 cell It has been reported that merlin overexpression apoptosis in the mechanism was not suggested H. Mol. Genet. 2002; PubMed Scopus (67) Google Scholar). This study that the activation of p53 by merlin could be of the by which merlin induces However, the in this may have a for this the cell the and the NIH3T3 cell high of merlin and p53 are not to they in The for this is not at this However, on the functional cooperation between p53 and merlin the cellular response to the and may not be the of cell It is that cell have for via or the for the growth arrest or the cell are negative for PTEN tumor suppressor, and the may have p53 the cell line T. M. H. T. N. Res. 1994; Google Scholar). In the of growth was that of it was not apoptosis was observed in cells or by the expression of merlin in NIH3T3 cells the normal This is in the line with that of H. Mol. Genet. 2002; PubMed Scopus (67) Google Scholar) that of merlin in cells for a of Therefore, that high expression of merlin or the such as serum and be for the and p53-dependent apoptosis of merlin can the activation or of merlin as a may the cell of tumors with non-functional merlin or Mdm2 overexpression. In the of PTEN, overexpression p53 from Mdm2-mediated degradation and the cell to (23Mayo L.D. Dixon J.E. Durden D.L. Tonks N.K. Donner D.B. J. Biol. Chem. 2002; 277: 5484-5489Abstract Full Text Full Text PDF PubMed Scopus (298) Google Scholar). In these results suggest a for the between the merlin and p53 tumor suppressors in tumor The mechanism to be We the other of this for

References

32